GLP-1 Dossier

Head to head

NovoCare Pharmacy vs Hims

Both are real, operating US telehealth companies. What separates them is what they supply, what they charge for it, and what regulators have published about each — all of it below, linked to the primary documents.

NovoCare Pharmacy
FDA-approved
$149/mo
Hims
FDA-approved
$149/mo
NovoCare Pharmacy on file
1
Hims on file
5

Side by side

What each one publishes about itself

Every figure here is the provider’s own advertised number, not an estimate. A dash means the company does not publish it.

NovoCare PharmacyHims
SuppliesFDA-approved medication onlyFDA-approved medication only
Advertised from$149/mo$149/mo
First month$199$39
Medication in the priceIncludedBilled separately
InsuranceCash payCash pay
IntakeAsync
On the record1 action5 actions

The difference that actually matters

Supplies FDA-approved medication only — Wegovy, Zepbound, Ozempic, Mounjaro or the approved oral versions. Higher priced, and outside the compounding enforcement entirely.

On price: NovoCare Pharmacy advertises from $149 a month and Hims from $149. Compare what the two figures cover before comparing the figures: NovoCare Pharmacy includes medication, Hims bills it separately.

What is on NovoCare Pharmacy’s record

2025-09

FDA warning letter to Novo Nordisk, Inc. over a prime-time TV special that created a misleading impression regarding product safety.

Primary source →

What is on Hims’s record

2025-09

FDA warning letter to Hims & Hers Health, Inc. dba Hims (MARCS-CMS 716567) over compounded GLP-1 marketing.

Primary source →

2025-06

Novo Nordisk terminated its collaboration with Hims & Hers, alleging illegal sham compounding and Chinese-sourced unapproved API.

Primary source →

2026-03

Novo Nordisk patent infringement suit filed February 2026 was dropped 9 March 2026 under a settlement in which Hims agreed to stop promoting compounded GLP-1s.

Primary source →

All 5 on the Hims page →

Go direct

Both companies, and what we earn from each

We do not recommend one over the other. Where a link pays us, it says so here and on the provider’s own page.

NovoCare Pharmacy

FDA-approved medication only, from $149 a month. 1 action on record, each linked on its page. The link below earns us nothing.

Hims

FDA-approved medication only, from $149 a month. 5 actions on record, each linked on its page. The link below earns us nothing.

Straight answers

NovoCare Pharmacy vs Hims, in short

Is NovoCare Pharmacy or Hims cheaper?
NovoCare Pharmacy advertises the lower starting price — $149 a month against $149. Whether that is the cheaper purchase depends on what each figure covers: NovoCare Pharmacy includes medication, and Hims bills it separately.
What is the difference between NovoCare Pharmacy and Hims?
Both supply the same category — FDA-approved medication only — so the differences are price, how the consultation works, and what each one has on its regulatory record.
Which one has more regulatory actions on record?
Hims, with 5 sourced actions against 1 action for NovoCare Pharmacy. Every one is linked to its primary document on the provider's own page. A larger file is not automatically a worse company — read what the documents actually say.

Other comparisons: Hims vs Ro (Ro Body) · Hims vs Hers · Hims vs Noom (Noom Med) · Hims vs Calibrate · Hims vs Henry Meds · Hims vs LillyDirect